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Introduction 
Maple syrup urine disease (MSUD) is a rare, inherited 
metabolic disease caused by a deficiency in 
branched-chain α-ketoacid dehydrogenase 
complex, an enzyme of the metabolic pathway of the 
three branched-chain amino acids, leucine, 
isoleucine, and valine [1]. It is characterized by 
psychomotor delay, hypotonia, seizures, and urine 
with a distinctive maple syrup odor. The aim of 
treatment aim is to reduce toxic metabolites that 
lead to cytotoxic brain edema. This is achieved by 
ensuring adherence to a restricted diet of branched-
chain amino acids that are commercially available as 
an infant formula [2]. The cutaneous manifestations 
of MSUD are infrequent and mainly comprise an 
acrodermatitis enteropathica-like dermatitis 
resulting from the restriction of selected amino acids 
[3]. Skin manifestations associated with therapy for 
this enzymatic deficiency have been reported in 
approximately 12 MSUD cases in the literature [4]. A 
case of dermatitis caused by branched-chain amino 
acid restriction that improved following dietary 
supplementation with leucine in the context of 
MSUD is described. 
 
Case Synopsis 
A one-year-old girl was diagnosed with MSUD at 
eight months following extensive epilepsy studies. 
She had no family history of consanguinity. She did 
have a family history of maternal epilepsy and a sister 
who died in the first two weeks of life. Her 
pharmacologic treatment was levetiracetam, a 
commercially available BCAA-restricted infant 
formula and a multivitamin supplement. 
She presented with a dermatitis that had evolved 
over two weeks and was characterized by 
erythematous macules and papules with a 
predominance in the diaper area, flexural sites, and 
proximal thighs. She also manifested with marked 
irritability and worsening hypotonia. The only 
periorificial site slightly involved was the perianal 
zone, but there were no changes in hair, nails, or 
mucous membranes. The possible presence of 
scabies was eliminated on direct observation of the 
skin scrapings. Topical zinc oxide with 1% 
hydrocortisone was initiated following an initial 
diagnosis of diaper dermatitis with“id” phenomenon. 
However, the dermatitis worsened over two weeks, 
affecting the occipital area, trunk, palms, soles, and 
buttocks. It was characterized by perifollicular 
papules and erythematous urticarial plaques, with 
erosions and brownish scales in the diaper area 
(Figure 1). An elevation in blood eosinophil count 
Abstract 
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(480 eosinophils per mm3) was noted. The 
levetiracetam was withdrawn. An intravenous 
administration of methylprednisolone (1mg/kg/day) 
was initiated on suspicion of drug eruption. There 
was no improvement after two days and an 
acrodermatitis enteropathica-like eruption was 
suspected because it was not responsive to 
corticosteroids and it exhibited eroded skin with 
some predominance in the diaper area. A skin biopsy 
was performed. The histopathologic examination is 
shown in Figure 2: 
Plasma zinc and ammonia levels were normal. Blood 
samples were sent to a specialized center to 
determine the leucine levels. In the interim, leucine 
was administered orally on suspicion of an amino 
acid deficit. The cutaneous lesions started to resolve 
over the next two days and were characterized by a 
faint erythema, generalized desquamation, and 
postinflammatory hyperpigmentation. The patient’s 
neurologic condition also improved, with decreased 
irritability and hypotonia. A few days later, a serum 
leucine level of 20μmol/L was confirmed (normal 
values are 80–200μmol/L).  
 
Case Discussion 
Maple syrup urine disease affects one in 86,800–
185,000 live births. It is more prevalent in 
populations with increased frequency of 
consanguinity [1]. The condition is characterized by 
elevation in branched-chain amino acids plasma 
levels and α-keto acid concentrations [1], thus 
triggering ketonuria, seizures, hypotonia, irritability, 
cognitive impairment, and death related to cerebral 
edema and herniation [5]. 
Isoleucine, an essential amino acid, is involved in 
keratinocyte growth and differentiation. Its 
depletion is correlated with arrested keratinocyte 
culture growth [6]. However, the skin manifestations 
are not primarily related to toxicity, but as a 
consequence of dietary restrictions [4]. 
Numerous metabolic deficits produce clinical 
entities typified by skin manifestations. Of these, an 
acrodermatitis enteropathica-like eruption is most 
frequently observed [4]. Other inherited metabolic 
diseases, such as methylmalonic and propionic,  
   
 
Figure 1. Cutaneous presentation. A) Perifollicular papules, 
erythematous plaques of the trunk and brownish crusts of the 
neck and shoulders. The child exhibited marked irritability. B) 
Erythematous plaques and brownish crusts with predominance 
in waist and buttocks, with scale in the margin of plaques.
 
 
 
 
Figure 2. A) Psoriasiform and superficial perivascular dermatitis 
with foci of parakeratosis. B) Epidermis showing spongiosis, 
keratinocytes with irregular contour nucleus, and broad 
eosinophilic cytoplasm. H&E, A) 100×; B) 400×.
A
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glutaric type I acidemia, ornithine transcarbamylase 
deficiency, and citrullinemia, exhibit cutaneous 
features that resemble acrodermatitis enteropathica 
[3, 7]. There are approximately 40 cases of 
acrodermatitis entropathica-like dermatitis in the 
literature, 13 of which involved a diagnosis of MSDU [4]. 
As in other cases related to amino acid restriction, the 
infant in this case presented with systemic disease 
manifestations, such as fever, irritability, and 
muscular weakness. This clinical scenario is typical of 
nutritional deficiency diseases and was not initially 
considered. However, the polymorphous eruption 
that began in the diaper area and consisted of 
erythematous papules and eroded plaques with 
crusts were suggestive of amino acid deficit in the 
clinical setting of innate metabolic diseases (MSUD 
or other enzymatic disorders). The intertriginous 
zones may be most affected because of repetitive 
cutaneous friction, causing increased epidermal 
turnover. The absence of mucosal involvement, 
particularly stomatitis and glosssitis, that is relatively 
common in acrodermatitis entropathica-like 
conditions, was an interesting finding in the current 
case [7]. This difference may relate to the minor role 
of leucine in mucosal morphology and epithelial 
replacement. 
Additionally, histopathology can be used to 
differentiate between other entities, such as 
necrolytic acral erythema and drug reactions. We are  
unaware of specific cutaneous MSUD lesions. These 
findings reported resemble the histological features 
present in other dermatoses related to micronutrient 
deficiencies [8]. The determination of ammonia 
blood levels is useful for evaluating the extent to 
which leucine is restricted if serum quantification 
levels of leucine, isoleucine, and valine are 
unavailable [9]. Ammonia is the final product of 
amino acid metabolism and indirectly reflects their 
deficit. If ammonia levels are normal or less than 
normal, leucine should be increased empirically in 
the diet [8, 9]. 
 
Conclusion 
It is important for dermatologists to be aware of 
signs of leucine deficit and monitor patients with 
clinical features of MSUD undergoing the treatment 
of amino acid restriction. Observation of the diaper 
area may be a key to early diagnosis. If dermatitis 
related to branched-chain amino acid restriction is 
suspected, a skin biopsy should be performed and 
the plasma levels of valine, leucine, isoleucine, and 
zinc should be assessed. Subsequently, ammonia 
levels may be monitored to assess leucine deficiency. 
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